TP53 and breast cancer: However, the affected pathways enriched in blood‐specific mutations were atypical for breast cancer, although some pathways were indeed meaningful to breast cancer, such as p53 signaling pathway, endocrine resistance, and mTOR signaling pathway (Fig. 2C).